Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials

• Matthew J. Shun-Shin, Sean L. Zheng, Graham D. Cole, James P. Howard, Zachary I. Whinnett, Darrel P. Francis

• European Heart Journal, February 2017, Oxford University Press (OUP)
• DOI: 10.1093/eurheartj/ehx028